Recordati is a well-established international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals with more than 4,300 employees listed on the Italian Stock Exchange since 1984. Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and the other C.I.S. countries, in Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia.
Recordati offers a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized segment dedicated to treatments for rare diseases. An efficient field force of medical representatives and orphan drug representatives promotes its products in about 150 markets.
Worldwide
Headcount4,300
HeadquartersVia M. Civitali 1, 20148 Milano – Italy
209,125,156
IPOJan. 1, 1984
Stock exchange(s)Borsa Italiana